A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Janice M. Mehnert, Ann W. Silk, J. H. Lee, Liesel Dudek, Byeong Seon Jeong, Jiadong Li, Jason M. Schenkel, Evita Sadimin, Michael Kane, Hongxia Lin, Weichung J. Shih, Andrew Zloza, Suzie Chen, James S. Goydos
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma'. Together they form a unique fingerprint.